Schedule 13D ownership disclosure

SOPHIA GENETICS SA

Ordinary Shares, par value CHF 0.05 per share · CUSIP: H82027105

Event date: 2026-11-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Schindel Yair ChaimReported CIK 0001823758

    Shares: 5,318,023.00 · Class: 6.2%

  • aMoon Growth Fund Limited Partnership

    Shares: 5,318,023.00 · Class: 6.2%

  • aMoon Growth Fund G.P. Limited Partnership

    Shares: 5,318,023.00 · Class: 6.2%

  • aMoon General Partner Ltd.

    Shares: 5,318,023.00 · Class: 6.2%

  • aMoon Edge Limited Partnership

    Shares: 0.00 · Class: 0%

  • aMoon Edge GP Ltd.

    Shares: 0.00 · Class: 0%

  • Hilliyon Holdings Ltd.

    Shares: 0.00 · Class: 0%

  • Berko Capital Ltd.

    Shares: 0.00 · Class: 0%

  • Dr. Tomer Berkovitz

    Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-26-005168
Form type
SCHEDULE 13D/A
Filer
SOPHiA GENETICS SA
CIK
CIK 1840706
Filed
Nov 12, 2026
Reporting period
Nov 10, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub